semaglutide daily mail Hope for new low cost slimming pill as tablet beats oral in trial Weight-loss jab Ozempic 'could help

SHANGHAI, March 6 () - China has approved Pfizer's GLP-1 treatment Xianweiying for long-term weight management in overweight or obese adults, the US drugmaker said on WeChat on Friday, boosting competition in a market analysts expect to be worth billions in coming years.The injection belongs to the class of GLP-1 receptor agonist drugs sold locally by drugmakers such as Novo Nordisk, Eli Lilly, and Innovent Biologics.

Stool softeners don't address the root cause

Diabetes is a public health problem with an estimated worldwide prevalence of 10% and a

Read to learn more!

On GLP-1 medication, every bite counts more

Compounded GLP-1 medications like semaglutide and tirzepatide may include additives such as B12, B6, glycine, and NAD to improve comfort, energy, and tolerability.